Dr. Bradley Corr spoke to the Mesothelioma Cancer Alliance about the promise and limitations of immunotherapy for cancer
In a fight against cancer, researchers have found great potential in harnessing and boosting the efforts of the immune system to attack the cancer cells. Cancer immunotherapy is still developing but has shown promise for a number of cancers already.
“Immunotherapy is a phenomenal new tool in our armament of treatment options for patients. However, it is certainly in its developmental stages in most cancers,” said Dr. Bradley Corr. “The way I see the research going and potential for its use is more as an addition to rather than a replacement for conventional treatment options.”
He added that immunotherapy success in some cancers has been quite high. But he cautioned that those successes haven’t translated across the board for all cancers.